Viewing Study NCT01870895


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-01-21 @ 10:22 AM
Study NCT ID: NCT01870895
Status: COMPLETED
Last Update Posted: 2015-10-12
First Post: 2013-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
Sponsor: Astellas Pharma Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 060-CL-702
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators